Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

Common colorectal cancer risk variants in SMAD7 are associated with survival among prediagnostic nonsteroidal anti-inflammatory drug users: a population-based study of postmenopausal women.

Passarelli MN, Coghill AE, Hutter CM, Zheng Y, Makar KW, Potter JD, Newcomb PA.

Genes Chromosomes Cancer. 2011 Nov;50(11):875-86. doi: 10.1002/gcc.20913. Epub 2011 Aug 24.

2.

Genome-wide association study identifies a new SMAD7 risk variant associated with colorectal cancer risk in East Asians.

Zhang B, Jia WH, Matsuo K, Shin A, Xiang YB, Matsuda K, Jee SH, Kim DH, Cheah PY, Ren Z, Cai Q, Long J, Shi J, Wen W, Yang G, Ji BT, Pan ZZ, Matsuda F, Gao YT, Oh JH, Ahn YO, Kubo M, Thean LF, Park EJ, Li HL, Park JW, Jo J, Jeong JY, Hosono S, Nakamura Y, Shu XO, Zeng YX, Zheng W.

Int J Cancer. 2014 Aug 15;135(4):948-55. doi: 10.1002/ijc.28733. Epub 2014 Jan 29.

3.

Phenotypic and tumor molecular characterization of colorectal cancer in relation to a susceptibility SMAD7 variant associated with survival.

Garcia-Albeniz X, Nan H, Valeri L, Morikawa T, Kuchiba A, Phipps AI, Hutter CM, Peters U, Newcomb PA, Fuchs CS, Giovannucci EL, Ogino S, Chan AT.

Carcinogenesis. 2013 Feb;34(2):292-8. doi: 10.1093/carcin/bgs335. Epub 2012 Oct 26.

4.

Correlation Between CASC8, SMAD7 Polymorphisms and the Susceptibility to Colorectal Cancer: An Updated Meta-Analysis Based on GWAS Results.

Yao K, Hua L, Wei L, Meng J, Hu J.

Medicine (Baltimore). 2015 Nov;94(46):e1884. doi: 10.1097/MD.0000000000001884.

5.

Intronic polymorphisms of the SMAD7 gene in association with colorectal cancer.

Damavand B, Derakhshani S, Saeedi N, Mohebbi SR, Milanizadeh S, Azimzadeh P, Aghdaie HA, Zali MR.

Asian Pac J Cancer Prev. 2015;16(1):41-4.

6.

Are SMAD7 rs4939827 and CHI3L1 rs4950928 polymorphisms associated with colorectal cancer in Egyptian patients?

Abd El-Fattah AA, Sadik NA, Shaker OG, Kamal AM.

Tumour Biol. 2016 Jul;37(7):9387-97. doi: 10.1007/s13277-016-4813-8. Epub 2016 Jan 16.

PMID:
26779637
7.

Association between colorectal cancer susceptibility loci and survival time after diagnosis with colorectal cancer.

Phipps AI, Newcomb PA, Garcia-Albeniz X, Hutter CM, White E, Fuchs CS, Hazra A, Ogino S, Nan H, Ma J, Campbell PT, Figueiredo JC, Peters U, Chan AT.

Gastroenterology. 2012 Jul;143(1):51-4.e4. doi: 10.1053/j.gastro.2012.04.052. Epub 2012 May 8.

8.

Common single-nucleotide polymorphisms in the estrogen receptor β promoter are associated with colorectal cancer survival in postmenopausal women.

Passarelli MN, Phipps AI, Potter JD, Makar KW, Coghill AE, Wernli KJ, White E, Chan AT, Hutter CM, Peters U, Newcomb PA.

Cancer Res. 2013 Jan 15;73(2):767-75. doi: 10.1158/0008-5472.CAN-12-2484. Epub 2012 Nov 13.

9.

Increased risk of colon cancer associated with a genetic polymorphism of SMAD7.

Slattery ML, Herrick J, Curtin K, Samowitz W, Wolff RK, Caan BJ, Duggan D, Potter JD, Peters U.

Cancer Res. 2010 Feb 15;70(4):1479-85. doi: 10.1158/0008-5472.CAN-08-1792. Epub 2010 Feb 2. Erratum in: Cancer Res. 2010 Apr 1;70(7):2996-7.

10.

SMAD7 and MGMT genotype variants and cancer incidence in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Norfolk Study.

Loh YH, Mitrou PN, Wood A, Luben RN, McTaggart A, Khaw KT, Rodwell SA.

Cancer Epidemiol. 2011 Aug;35(4):369-74. doi: 10.1016/j.canep.2010.09.011. Epub 2010 Nov 12.

PMID:
21075068
11.

Colorectal cancer-susceptibility single-nucleotide polymorphisms in Korean population.

Hong SN, Park C, Kim JI, Kim DH, Kim HC, Chang DK, Rhee PL, Kim JJ, Rhee JC, Son HJ, Kim YH.

J Gastroenterol Hepatol. 2015 May;30(5):849-57. doi: 10.1111/jgh.12331.

PMID:
23875689
12.

Genetic variations in SMAD7 are associated with colorectal cancer risk in the colon cancer family registry.

Jiang X, Castelao JE, Vandenberg D, Carracedo A, Redondo CM, Conti DV, Paredes Cotoré JP, Potter JD, Newcomb PA, Passarelli MN, Jenkins MA, Hopper JL, Gallinger S, Le Marchand L, Martínez ME, Ahnen DJ, Baron JA, Lindor NM, Haile RW, Gago-Dominguez M.

PLoS One. 2013;8(4):e60464. doi: 10.1371/journal.pone.0060464. Epub 2013 Apr 3.

13.

SMAD7 variant rs4939827 is associated with colorectal cancer risk in Croatian population.

Kirac I, Matošević P, Augustin G, Šimunović I, Hostić V, Župančić S, Hayward C, Antoljak N, Rudan I, Campbell H, Dunlop MG, Velimir Vrdoljak D, Kovačević D, Zgaga L.

PLoS One. 2013 Sep 16;8(9):e74042. doi: 10.1371/journal.pone.0074042. eCollection 2013 Sep 16.

14.

Prediagnostic non-steroidal anti-inflammatory drug use and survival after diagnosis of colorectal cancer.

Coghill AE, Newcomb PA, Campbell PT, Burnett-Hartman AN, Adams SV, Poole EM, Potter JD, Ulrich CM.

Gut. 2011 Apr;60(4):491-8. doi: 10.1136/gut.2010.221143. Epub 2010 Nov 4.

15.

Multiple functional risk variants in a SMAD7 enhancer implicate a colorectal cancer risk haplotype.

Fortini BK, Tring S, Plummer SJ, Edlund CK, Moreno V, Bresalier RS, Barry EL, Church TR, Figueiredo JC, Casey G.

PLoS One. 2014 Nov 6;9(11):e111914. doi: 10.1371/journal.pone.0111914. eCollection 2014 Nov 6.

16.

A genome-wide association study shows that common alleles of SMAD7 influence colorectal cancer risk.

Broderick P, Carvajal-Carmona L, Pittman AM, Webb E, Howarth K, Rowan A, Lubbe S, Spain S, Sullivan K, Fielding S, Jaeger E, Vijayakrishnan J, Kemp Z, Gorman M, Chandler I, Papaemmanuil E, Penegar S, Wood W, Sellick G, Qureshi M, Teixeira A, Domingo E, Barclay E, Martin L, Sieber O; CORGI Consortium., Kerr D, Gray R, Peto J, Cazier JB, Tomlinson I, Houlston RS.

Nat Genet. 2007 Nov;39(11):1315-7. Epub 2007 Oct 14.

PMID:
17934461
17.

Genetic variations in the TGFβ signaling pathway, smoking and risk of colorectal cancer in a Chinese population.

Zhong R, Liu L, Zou L, Sheng W, Zhu B, Xiang H, Chen W, Chen J, Rui R, Zheng X, Yin J, Duan S, Yang B, Sun J, Lou J, Liu L, Xie D, Xu Y, Nie S, Miao X.

Carcinogenesis. 2013 Apr;34(4):936-42. doi: 10.1093/carcin/bgs395. Epub 2012 Dec 28.

PMID:
23275154
18.

Genetic variation in prostaglandin synthesis and related pathways, NSAID use and colorectal cancer risk in the Colon Cancer Family Registry.

Resler AJ, Makar KW, Heath L, Whitton J, Potter JD, Poole EM, Habermann N, Scherer D, Duggan D, Wang H, Lindor NM, Passarelli MN, Baron JA, Newcomb PA, Le Marchand L, Ulrich CM.

Carcinogenesis. 2014 Sep;35(9):2121-6. doi: 10.1093/carcin/bgu119. Epub 2014 Jun 7.

19.

Non-steroidal anti-inflammatory drugs and colorectal cancer risk in a large, prospective cohort.

Ruder EH, Laiyemo AO, Graubard BI, Hollenbeck AR, Schatzkin A, Cross AJ.

Am J Gastroenterol. 2011 Jul;106(7):1340-50. doi: 10.1038/ajg.2011.38. Epub 2011 Mar 15.

20.

Colorectal cancer after start of nonsteroidal anti-inflammatory drug use.

Stürmer T, Buring JE, Lee IM, Kurth T, Gaziano JM, Glynn RJ.

Am J Med. 2006 Jun;119(6):494-502.

Supplemental Content

Support Center